Literature DB >> 26064378

Angiotensinogen gene M235T and angiotensin II-type 1 receptor gene A/C1166 polymorphisms in chronic obtructive pulmonary disease.

Ceylan Ayada1, Ümran Toru2, Osman Genç1, Server Şahin3, Sebahat Turgut4, Günfer Turgut4.   

Abstract

Chronic obstructive pulmonary disease (COPD) occurs irreversibly and is characterized by progressive airflow obstruction. Renin angiotensin system (RAS) has many different key enzymes and receptors that have a role for different systemic processes. We aimed to determine genotype and allele frequencies of angiotensinogen (AGT) M235T and angiotensin II-type 1 receptor (AT1-R) A/C1166 polymorphisms in patients with COPD. This study was performed on 56 unrelated COPD patients and 29 healthy subjects. DNA samples for each individual were isolated from peripheral blood by phenol/chloroform method, analyzed by polymerase chain reaction and enzymatic digestion methodologies. The distribution for each of AGT genotypes were 23.2% for MM (13), 75.0% for MT (42) and 1.8% for TT (1) in the COPD group; 37.9% for MM (11), 34.5% for MT (10) and 27.6% for TT (8) in the control group. The distribution of AGT genotypes was found significantly different between groups (X(2) = 18.604; df = 2; P = 0.000). The frequencies for each of the AT1-R genotypes were found as 53.6% for AA (30), 42.9% for AC (24), 3.6% for CC (2) in the COPD group; 55.2% for AA (16), 41.4% for AC (12) and 3.4% for CC (1) in the control group. The distribution of AT1-R genotypes did not change significantly between groups. Allele frequencies of interested genes were not significantly different between groups. We suggest that AGT polymorphism may play a role for the development of COPD. We believe these data can be served for large scale population genetics research, considering the frequency of AGT and AT1-R genes and alleles in COPD patients in the Turkish population.

Entities:  

Keywords:  A/C1166 polymorphism; Angiotensinogen; M235T polymorphism; angiotensin-II type 1 receptor; chronic obstructive pulmonary disease

Year:  2015        PMID: 26064378      PMCID: PMC4443212     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Angiotensin converting enzyme I/D, angiotensinogen M235T and AT1-R A/C1166 gene polymorphisms in patients with acromegaly.

Authors:  Sebahat Turgut; Fulya Akın; Raziye Akcılar; Ceylan Ayada; Günfer Turgut
Journal:  Mol Biol Rep       Date:  2010-04-02       Impact factor: 2.316

2.  Association of 3 gene polymorphisms with atopic diseases.

Authors:  L Hollá; A Văsků; V Znojil; L Sisková; J Vácha
Journal:  J Allergy Clin Immunol       Date:  1999-04       Impact factor: 10.793

3.  Rapid detection of the hypertension-associated Met235-->Thr allele of the human angiotensinogen gene.

Authors:  A P Russ; W Maerz; V Ruzicka; U Stein; W Gross
Journal:  Hum Mol Genet       Date:  1993-05       Impact factor: 6.150

4.  Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.

Authors:  Wilfried Renner; Markus Nauck; Bernhard R Winkelmann; Michael M Hoffmann; Hubert Scharnagl; Volker Mayer; Bernhard O Boehm; Winfried März
Journal:  J Mol Med (Berl)       Date:  2004-12-15       Impact factor: 4.599

5.  Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries.

Authors:  P P van Geel; Y M Pinto; A A Voors; H Buikema; M Oosterga; H J Crijns; W H van Gilst
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

Review 6.  Angiotensinogen: molecular biology, biochemistry and physiology.

Authors:  L Morgan; F Broughton Pipkin; N Kalsheker
Journal:  Int J Biochem Cell Biol       Date:  1996-11       Impact factor: 5.085

Review 7.  The M235T polymorphism in the angiotensinogen gene and heart failure: a meta-analysis.

Authors:  Song Chen; Lan Zhang; Hong-Wei Wang; Xiao-Yun Wang; Xue-Qi Li; Li-Li Zhang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-11-15       Impact factor: 1.636

8.  Molecular basis of human hypertension: role of angiotensinogen.

Authors:  X Jeunemaitre; F Soubrier; Y V Kotelevtsev; R P Lifton; C S Williams; A Charru; S C Hunt; P N Hopkins; R R Williams; J M Lalouel
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

9.  Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD).

Authors:  Janet G Shaw; Annette G Dent; Linda H Passmore; Darryl J Burstow; Rayleen V Bowman; Paul V Zimmerman; Kwun M Fong; Ian A Yang
Journal:  BMC Pulm Med       Date:  2012-06-13       Impact factor: 3.317

Review 10.  Renin-angiotensin system revisited.

Authors:  F Fyhrquist; O Saijonmaa
Journal:  J Intern Med       Date:  2008-09       Impact factor: 8.989

View more
  3 in total

Review 1.  The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.

Authors:  Gillian A Kelly-Robinson; James A Reihill; Fionnuala T Lundy; Lorcan P McGarvey; John C Lockhart; Gary J Litherland; Keith D Thornbury; S Lorraine Martin
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

2.  SERPINE1 -844 and -675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population.

Authors:  Xia Xu; Hongchao Wang; Haijun Li; Xiaopei Cui; Hongyu Zhang
Journal:  J Int Med Res       Date:  2016-11-18       Impact factor: 1.671

3.  The Severity of Oxidative Stress in Comorbid Chronic Obstructive Pulmonary Disease (COPD) and Hypertension: Does it Depend On ACE and AGT Gene Polymorphisms?

Authors:  Mariya Marushchak; Khrystyna Maksiv; Inna Krynytska; Olha Dutchak; Nina Behosh
Journal:  J Med Life       Date:  2019 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.